Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sengottuvel Viswanathan"'
Autor:
Urvi A. Shah, Sengottuvel Viswanathan, Beamon Agarwal, Aditi Shastri, Ioannis Mantzaris, Murali Janakiram, Noah Kornblum, Ira Braunschweig, Amit Verma, Yang Shi, John Reinus, Olga Derman
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
SOS is a rare complication of stem cell transplantation and has significant morbidity and mortality. We present three cases of SOS and highlight underlying risk factors for its development, such as impaired clearance of alkylating agents (especially
Externí odkaz:
https://doaj.org/article/73be8317410748d49f5fa14e9d3d2e4c
Autor:
Radhashree Maitra, Matthew Coffey, Himanshu Kharkwal, Sengottuvel Viswanathan, Umang Shah, Imran Chaudhary, Mohammad H. Ghalib, Ruwan Y. Parakrama, Allyson J. Ocean, Sanjay Goel
Supplementary table 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67ba916f3216620ad1c92d47d562059f
https://doi.org/10.1158/1535-7163.22520730.v1
https://doi.org/10.1158/1535-7163.22520730.v1
Autor:
Radhashree Maitra, Matthew Coffey, Himanshu Kharkwal, Sengottuvel Viswanathan, Umang Shah, Imran Chaudhary, Mohammad H. Ghalib, Ruwan Y. Parakrama, Allyson J. Ocean, Sanjay Goel
KRAS mutation is a negative predictive biomarker of anti-EGFR agents in patients with metastatic colorectal cancer (mCRC), and remains an elusive target. Pelareorep, a double-stranded RNA virus selectively replicates in KRAS-mutated cells, and is syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50fae593802becc4a74d8b18c0ba36df
https://doi.org/10.1158/1535-7163.c.6542748
https://doi.org/10.1158/1535-7163.c.6542748
Autor:
Umang Shah, Matthew C. Coffey, Himanshu Kharkwal, Sanjay Goel, Allyson J. Ocean, Sengottuvel Viswanathan, Imran Chaudhary, M. H. Ghalib, Ruwan Parakrama, Radhashree Maitra
Publikováno v:
Molecular Cancer Therapeutics. 19:1148-1156
KRAS mutation is a negative predictive biomarker of anti-EGFR agents in patients with metastatic colorectal cancer (mCRC), and remains an elusive target. Pelareorep, a double-stranded RNA virus selectively replicates in KRAS-mutated cells, and is syn
Autor:
John F. Reinus, Amit Verma, Noah Kornblum, Yang Shi, Olga Derman, Urvi A Shah, Sengottuvel Viswanathan, Ioannis Mantzaris, Beamon Agarwal, Ira Braunschweig, Murali Janakiram, Aditi Shastri
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine
SOS is a rare complication of stem cell transplantation and has significant morbidity and mortality. We present three cases of SOS and highlight underlying risk factors for its development, such as impaired clearance of alkylating agents (especially
Autor:
Sanjay, Goel, Allyson J, Ocean, Ruwan Y, Parakrama, Mohammad H, Ghalib, Imran, Chaudhary, Umang, Shah, Sengottuvel, Viswanathan, Himanshu, Kharkwal, Matthew, Coffey, Radhashree, Maitra
Publikováno v:
Mol Cancer Ther
KRAS mutation is a negative predictive biomarker of anti-EGFR agents in patients with metastatic colorectal cancer (mCRC), and remains an elusive target. Pelareorep, a double-stranded RNA virus selectively replicates in KRAS mutated cells, and is syn
Autor:
Sanjay Goel, Sengottuvel Viswanathan, Umang Shah, Ioannis Mantzaris, Audrey E. Kam, Imran Chaudhary, Gopichand Pendurti, M. H. Ghalib
Publikováno v:
Journal of Clinical Oncology. 36:828-828
828 Background: Pts with mCRC who progress on all standard therapies have a poor prognosis and limited therapy options. Phase 1 trials represent a valuable treatment option. Herein we report the characteristics and outcomes of mCRC patients treated a
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 75:190